Injected drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called IDOV-SAFE that is injected directly into a tumor. It is for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the injection is safe and can shrink the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have an advanced solid tumor (like breast cancer, melanoma, head/neck, colon, bile duct, pancreas, or liver cancer) that has gotten worse after standard treatment, or you cannot have standard treatment.
- You have at least one tumor that can be injected with a needle, either just under the skin or guided by a CT or ultrasound.
- You are in good general health (able to do most daily activities on your own).
- Your liver, kidneys, and blood counts are within certain safe limits.
- You are willing to use birth control for 90 days after the study, if you or your partner could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called IDOV-SAFE given through a vein. It is for people with advanced solid tumors that have not responded to standard treatments. The study aims to see if the drug is safe and if it can help shrink tumors.
This trial tests a new drug called JSKN027 for people with advanced solid tumors (cancers that have spread) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink tumors.
This trial tests a new intravenous drug called IDOV-SAFE in people with advanced solid tumors that have stopped responding to standard treatments or have no effective standard option. The goal is to see if it is safe and effective.
This trial tests an investigational drug called IDOV-Immune for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and effective.
This trial tests an investigational drug for people with advanced digestive system cancers (like colorectal, stomach, or liver cancer) that have stopped responding to standard treatments. The goal is to see if the drug is safe and helps control the cancer.
This trial tests an experimental virus-based treatment for people with advanced solid tumors that have stopped responding to standard therapies. The treatment is designed to infect and destroy cancer cells while boosting the immune system.
Hear when a new Advanced Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.